Piers Morgan
Chief Financial Officer
Piers is Chief Financial Officer at Pangea Bio. He has more than 20 years Board level experience in drug discovery, clinical development in biotech, covering both small molecules and gene therapies. To date, he served as Chairman of Ikarovec Ltd, CEO of C4X Discovery Ltd, as well as CFO of CellCentric Ltd, COMPASS Pathways, Verona Pharma, and uniQure NV.
Prior to his experience in biotech, Piers worked in investment banking for almost 10 years, focusing on M&A and equity capital markets; he holds an MA in Law and Management Studies from Cambridge University and qualified as an ACA with PricewaterhouseCoopers.
